InDevR Raises $9 Million in Series B Financing and Partners with bioMérieux
Boulder, CO, 17 January 2023 – InDevR, Inc., a [...]
Boulder, CO, 17 January 2023 – InDevR, Inc., a [...]
[Press Release] InDevR launches a new product that could shave weeks [...]
InDevR plans to launch a Research Use Only version of [...]
I&L showcased InDevR products at the World Vaccine Congress in [...]
InDevR licenses Mount Sinai influenza antibodies for VaxArray neuraminidase potency [...]